The local medical sector is abuzz with the emergence of retatrutide, a innovative dual GIP and GLP-1 medication showing remarkable results in early trials for treating obesity. This medication suggests a https://thefairlist.com/story12029092/retatrutide-australia-a-emerging-hope-for-weight-management